Tropomyosin α Polyclonal Antibody

    • Catalog No.:YT4746
    • Applications:WB,ELISA
    • Reactivity:Human,Mouse,Rat
      • Gene Name:
      • TPM1
      • Protein Name:
      • Tropomyosin alpha-1 chain
      • Human Gene Id:
      • 7168
      • Human Swiss Prot No:
      • P09493
      • Mouse Swiss Prot No:
      • P58771
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human Tropomyosin alpha. AA range:40-89
      • Specificity:
      • Tropomyosin α Polyclonal Antibody detects endogenous levels of Tropomyosin α protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Rabbit
      • Dilution:
      • Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -20°C/1 year
      • Other Name:
      • TPM1; C15orf13; TMSA; Tropomyosin alpha-1 chain; Alpha-tropomyosin; Tropomyosin-1
      • MolecularWeight(Da):
      • 32709
      • Observed Band(KD):
      • 35
      • Background:
      • tropomyosin 1 (alpha)(TPM1) Homo sapiens This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy. [provided by
      • Function:
      • alternative products:Additional isoforms seem to exist,disease:Defects in TPM1 are the cause of cardiomyopathy dilated type 1Y (CMD1Y) [MIM:611878]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.,disease:Defects in TPM1 are the cause of cardiomyopathy familial hypertrophic type 3 (CMH3) [MIM:115196]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudde
      • Subcellular Location:
      • stress fiber,cytosol,cytoskeleton,muscle thin filament tropomyosin,actin filament,integral component of membrane,myofibril,sarcomere,filamentous actin,bleb,ruffle membrane,
      • Expression:
      • Brain,Caudate nucleus,Colon,Fibroblast,Heart,Hippocampus,Liver,Mammary cancer,Place
      • Products Images
      • Western Blot analysis of various cells using Tropomyosin α Polyclonal Antibody. Secondary antibody(catalog#:RS0002) was diluted at 1:20000
      • Western blot analysis of lysate from HeLa cells, using Tropomyosin α antibody.